Why Medical Cannabis Won the Rescheduling Fight and What That Means for Valuation
A 2026 Department of Justice order moved licensed medical marijuana into Schedule III while leaving adult-use in Schedule I. The result: identical revenue can produce very different after-tax profits, and buyers must price medical revenue differently from adult-use.




